Abstract
The concept of immune privilege suggests that the central nervous system is isolated from the immune system. However, recent studies have highlighted the borders of the central nervous system as central sites of neuro-immune interactions. Although the nervous and immune systems both function to maintain homeostasis, under rare circumstances, they can develop pathological interactions that lead to neurological or psychiatric diseases. Here we discuss recent findings that dissect the key anatomical, cellular and molecular mechanisms that enable neuro-immune responses at the borders of the brain and spinal cord and the implications of these interactions for diseases of the central nervous system.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Herz, J. et al. GABAergic neuronal IL-4R mediates T cell effect on memory. Neuron 109, 3609–3618.e9 (2021).
Alves de Lima, K. et al. Meningeal γδ T cells regulate anxiety-like behavior via IL-17a signaling in neurons. Nat. Immunol. 21, 1421–1429 (2020).
Choi, G. B. et al. The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science 351, 933–939 (2016).
Mikami, N. et al. Calcitonin gene-related peptide is an important regulator of cutaneous immunity: effect on dendritic cell and T cell functions. J. Immunol. 186, 6886–6893 (2011).
Qian, J., Galitovskiy, V., Chernyavsky, A. I., Marchenko, S. & Grando, S. A. Plasticity of the murine spleen T-cell cholinergic receptors and their role in in vitro differentiation of naïve CD4 T cells toward the Th1, Th2 and Th17 lineages. Genes Immun. 12, 222–230 (2011).
Li, S. et al. Interleukin-13 and its receptor are synaptic proteins involved in plasticity and neuroprotection. Preprint at bioRxiv https://doi.org/10.1101/2021.12.01.470746 (2021).
Lee, H. et al. Synapse elimination and learning rules coregulated by MHC class I H2-Db. Nature 509, 195–200 (2014).
Wang, C. et al. Microglia mediate forgetting via complement-dependent synaptic elimination. Science 367, 688–694 (2020).
Zhang, B. et al. B cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity. Nature 599, 471–476 (2021).
Reed, M. D. et al. IL-17a promotes sociability in mouse models of neurodevelopmental disorders. Nature 577, 249–253 (2020).
Salvador, A. F., de Lima, K. A. & Kipnis, J. Neuromodulation by the immune system: a focus on cytokines. Nat. Rev. Immunol. 21, 526–541 (2021).
Ding, X. et al. Panicle-shaped sympathetic architecture in the spleen parenchyma modulates antibacterial innate immunity. Cell Rep. 27, 3799–3807.e3 (2019).
Huang, S. et al. Lymph nodes are innervated by a unique population of sensory neurons with immunomodulatory potential. Cell 184, 441–459.e25 (2021).
Goldman, D. H. et al. Age-associated suppression of exploratory activity during sickness is linked to meningeal lymphatic dysfunction and microglia activation. Nat. Aging 2, 704–713 (2022).
Koren, T. et al. Insular cortex neurons encode and retrieve specific immune responses. Cell 184, 5902–5915.e17 (2021).
Schulz, M. & Engelhardt, B. The circumventricular organs participate in the immunopathogenesis of experimental autoimmune encephalomyelitis. Cerebrospinal Fluid Res. 2, 8 (2005).
Engelhardt, B. & Coisne, C. Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle. Fluids Barriers CNS 8, 4 (2011).
Engelhardt, B., Vajkoczy, P. & Weller, R. O. The movers and shapers in immune privilege of the CNS. Nat. Immunol. 18, 123–131 (2017).
Forrester, J. V., McMenamin, P. G. & Dando, S. J. CNS infection and immune privilege. Nat. Rev. Neurosci. 19, 655–671 (2018).
Galea, I., Bechmann, I. & Perry, V. H. What is immune privilege (not)? Trends Immunol. 28, 12–18 (2007).
Louveau, A., Harris, T. H. & Kipnis, J. Revisiting the concept of CNS immune privilege. Trends Immunol. 36, 569–577 (2015).
Murphy, J. B. & Sturm, E. Conditions determining the transplantability of tissues in the brain. J. Exp. Med. 38, 183–197 (1923).
Medawar, P. B. Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br. J. Exp. Pathol. 29, 58–69 (1948).
Cserr, H. F., Harling-Berg, C. J. & Knopf, P. M. Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance. Brain Pathol. 2, 269–276 (1992).
Sun, D., Qin, Y., Chluba, J., Epplen, J. T. & Wekerle, H. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T–T cell interactions. Nature 332, 843–845 (1988).
Hickey, W. F., Hsu, B. L. & Kimura, H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28, 254–260 (1991).
Iliff, J. J. et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci. Transl. Med. 4, 147ra111 (2012).
Louveau, A. et al. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat. Neurosci. 21, 1380–1391 (2018).
Song, E. et al. VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours. Nature 577, 689–694 (2020). This study demonstrates how augmentation of meningeal lymphatic drainage can enhance CNS antigen drainage and promote T cell-mediated rejection of primary brain tumours.
Carare, R. O. et al. Clearance of interstitial fluid (ISF) and CSF (CLIC) group—part of Vascular Professional Interest Area (PIA). Alzheimers Dement. 12, e12053 (2020).
Hawkes, C. A., Jayakody, N., Johnston, D. A., Bechmann, I. & Carare, R. O. Failure of perivascular drainage of β-amyloid in cerebral amyloid angiopathy. Brain Pathol. 24, 396–403 (2014).
Hu, X. et al. Meningeal lymphatic vessels regulate brain tumor drainage and immunity. Cell Res. 30, 229–243 (2020).
Rustenhoven, J. A privileged brain. Science 374, 548–548 (2021).
Rustenhoven, J. et al. Functional characterization of the dural sinuses as a neuroimmune interface. Cell 184, 1000–1016.e27 (2021). This study reveals how exposure to CNS antigens and immune trafficking via the dural sinuses enables antigen presentation and immune surveillance of the brain from a distal site.
Mazzitelli, J. A. et al. Cerebrospinal fluid regulates skull bone marrow niches via direct access through dural channels. Nat. Neurosci. 25, 555–560 (2022). This study reveals how CSF can access CNS-associated bone marrow and enhance haematopoiesis and immune cell migration under inflammatory conditions.
Pulous, F. E. et al. Cerebrospinal fluid can exit into the skull bone marrow and instruct cranial hematopoiesis in mice with bacterial meningitis. Nat. Neurosci. 25, 567–576 (2022). This study reveals how CSF can access the skull bone marrow and enhance haematopoiesis following CNS infection.
Ringstad, G. & Eide, P. K. Molecular trans-dural efflux to skull bone marrow in humans with cerebrospinal fluid disorders. Brain J. Neurol. 145, 1464–1472 (2021). This study reveals how the CSF efflux routes to the skull bone marrow observed in rodents are conserved in humans.
Wang, Y. et al. Early developing B cells undergo negative selection by central nervous system-specific antigens in the meninges. Immunity 54, 2784–2794.e6 (2021). This study demonstrates how exposure to CNS-derived antigens in the dural mater shapes the B cell repertoire and contributes to immune tolerance by eliminating cells with CNS-reactive B cell receptors.
Fitzpatrick, Z. et al. Gut-educated IgA plasma cells defend the meningeal venous sinuses. Nature 587, 472–476 (2020). This study demonstrates the importance of dural sinus-associated plasma cells as a first-line of defence in preventing CNS infection by blood pathogens.
Ribeiro, M. et al. Meningeal γδ T cell-derived IL-17 controls synaptic plasticity and short-term memory. Sci. Immunol. 4, eaay5199 (2019).
Filiano, A. J. et al. Unexpected role of interferon-γ in regulating neuronal connectivity and social behaviour. Nature 535, 425–429 (2016).
Cugurra, A. et al. Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma. Science 373, eabf7844 (2021). This study highlights how the CNS-associated bone marrow can supply myeloid cells to the brain and spinal cord meninges under homeostasis and during diverse pathologies.
Brioschi, S. et al. Heterogeneity of meningeal B cells reveals a lymphopoietic niche at the CNS borders. Science 373, eabf9277 (2021). This study demonstrates how the CNS-associated bone marrow can supply B cells to the meninges and how the meninges function as an active site for B cell maturation.
Herisson, F. et al. Direct vascular channels connect skull bone marrow and the brain surface enabling myeloid cell migration. Nat. Neurosci. 21, 1209–1217 (2018). This study was the first to identify the presence of skull bone marrow channels that connect this haematopoietic site with the underlying brain meninges, enabling immune cell trafficking.
Siegenthaler, J. A. & Pleasure, S. J. We have got you ‘covered’: how the meninges control brain development. Curr. Opin. Genet. Dev. 21, 249–255 (2011).
Siegenthaler, J. A. et al. Retinoic acid from the meninges regulates cortical neuron generation. Cell 139, 597–609 (2009).
Mrdjen, D. et al. High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease. Immunity 48, 380–395.e6 (2018).
Van Hove, H. et al. A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment. Nat. Neurosci. 22, 1021–1035 (2019). This study provides a comprehensive atlas of immune cell populations at the various CNS borders including the dura, leptomeninges and choroid plexus.
Ajami, B. et al. Single-cell mass cytometry reveals distinct populations of brain myeloid cells in mouse neuroinflammation and neurodegeneration models. Nat. Neurosci. 21, 541–551 (2018).
Drieu, A. et al. Parenchymal border macrophages regulate the flow dynamics of the cerebrospinal fluid. Nature 611, 585–593 (2022).
Gate, D. et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer’s disease. Nature 577, 399–404 (2020). This study highlights the importance of adaptive immune cells in the brain borders of human neurodegenerative disease by demonstrating the presence of clonally expanded T cells that recognize Epstein–Barr viral antigens in the CSF of patients with Alzheimer’s disease.
Schafflick, D. et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat. Commun. 11, 247 (2020).
Gadani, S. P., Smirnov, I., Wiltbank, A. T., Overall, C. C. & Kipnis, J. Characterization of meningeal type 2 innate lymphocytes and their response to CNS injury. J. Exp. Med. 214, 285–296 (2017).
Merlini, A. et al. Distinct roles of the meningeal layers in CNS autoimmunity. Nat. Neurosci. 25, 887–899 (2022).
Schläger, C. et al. Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid. Nature 530, 349–353 (2016).
Derecki, N. C. et al. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J. Exp. Med. 207, 1067–1080 (2010).
Chaskiel, L. et al. Interleukin-1 reduces food intake and body weight in rat by acting in the arcuate hypothalamus. Brain. Behav. Immun. 81, 560–573 (2019).
Daneman, R. & Prat, A. The blood–brain barrier. Cold Spring Harb. Perspect. Biol. 7, a020412 (2015).
Munji, R. N. et al. Profiling the mouse brain endothelial transcriptome in health and disease models reveals a core blood–brain barrier dysfunction module. Nat. Neurosci. 22, 1892–1902 (2019).
Kawakami, N. et al. Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion. J. Exp. Med. 201, 1805–1814 (2005).
Ringstad, G. & Eide, P. K. Cerebrospinal fluid tracer efflux to parasagittal dura in humans. Nat. Commun. 11, 354 (2020). This study reveals how the CSF efflux routes to the dural sinuses observed in rodents are conserved in humans.
Eide, P. K. & Ringstad, G. Cerebrospinal fluid egress to human parasagittal dura and the impact of sleep deprivation. Brain Res. 1772, 147669 (2021).
Schafflick, D. et al. Single-cell profiling of CNS border compartment leukocytes reveals that B cells and their progenitors reside in non-diseased meninges. Nat. Neurosci. 24, 1225–1234 (2021).
Absinta, M. et al. Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI. eLife 6, e29738 (2017).
Louveau, A. et al. Structural and functional features of central nervous system lymphatics. Nature 523, 337–341 (2015). This study demonstrates the presence of a lymphatic network in the dural meninges that drains cerebrospinal fluid.
Aspelund, A. et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J. Exp. Med. 212, 991–999 (2015). This study demonstrates the presence of a lymphatic network in the dural meninges that drains CSF.
Castranova, D. et al. Live imaging of intracranial lymphatics in the zebrafish. Circ. Res. 128, 42–58 (2021).
Antila, S. et al. Development and plasticity of meningeal lymphatic vessels. J. Exp. Med. 214, 3645–3667 (2017).
Ahn, J. H. et al. Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid. Nature 572, 62–66 (2019).
Da Mesquita, S. et al. Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy. Nature 593, 255–260 (2021).
Da Mesquita, S. et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease. Nature 560, 185–191 (2018).
Ang, P. S., Matrongolo, M. J. & Tischfield, M. A. The growth and expansion of meningeal lymphatic networks are affected in craniosynostosis. Development 149, dev200065 (2022).
Jacob, L. et al. Conserved meningeal lymphatic drainage circuits in mice and humans. J. Exp. Med. 219, e20220035 (2022). This study highlights the key pathways for lymphatic drainage of CSF in rodents and demonstrates how these are conserved in humans.
Masuda, T. et al. Specification of CNS macrophage subsets occurs postnatally in defined niches. Nature 604, 740–748 (2022).
MacAulay, N., Keep, R. F. & Zeuthen, T. Cerebrospinal fluid production by the choroid plexus: a century of barrier research revisited. Fluids Barriers CNS 19, 26 (2022).
Dani, N. et al. A cellular and spatial map of the choroid plexus across brain ventricles and ages. Cell 184, 3056–3074.e21 (2021). This study provides a comprehensive atlas for probing choroid plexus immune cell phenotypes across distinct anatomical regions and during development.
Shipley, F. B. et al. Tracking calcium dynamics and immune surveillance at the choroid plexus blood–cerebrospinal fluid interface. Neuron 108, 623–639.e10 (2020).
Shechter, R. et al. Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity 38, 555–569 (2013).
Strominger, I. et al. The choroid plexus functions as a niche for T-cell stimulation within the central nervous system. Front. Immunol. 9, 1066 (2018).
Upton, M. L. & Weller, R. O. The morphology of cerebrospinal fluid drainage pathways in human arachnoid granulations. J. Neurosurg. 63, 867–875 (1985).
Ma, Q., Ineichen, B. V., Detmar, M. & Proulx, S. T. Outflow of cerebrospinal fluid is predominantly through lymphatic vessels and is reduced in aged mice. Nat. Commun. 8, 1434 (2017).
Decker, Y. et al. Magnetic resonance imaging of cerebrospinal fluid outflow after low-rate lateral ventricle infusion in mice. JCI Insight 8, e150881 (2022).
Ma, Q. et al. Rapid lymphatic efflux limits cerebrospinal fluid flow to the brain. Acta Neuropathol. 137, 151–165 (2019).
Hsu, M. et al. Neuroinflammation-induced lymphangiogenesis near the cribriform plate contributes to drainage of CNS-derived antigens and immune cells. Nat. Commun. 10, 229 (2019).
Zou, W. et al. Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein. Transl. Neurodegener. 8, 7 (2019).
Fabriek, B. O. et al. In vivo detection of myelin proteins in cervical lymph nodes of MS patients using ultrasound-guided fine-needle aspiration cytology. J. Neuroimmunol. 161, 190–194 (2005).
Yao, H. et al. Leukaemia hijacks a neural mechanism to invade the central nervous system. Nature 560, 55–60 (2018).
Cai, R. et al. Panoptic imaging of transparent mice reveals whole-body neuronal projections and skull-meninges connections. Nat. Neurosci. 22, 317–327 (2019).
Derk, J., Jones, H. E., Como, C., Pawlikowski, B. & Siegenthaler, J. A. Living on the edge of the CNS: meninges cell diversity in health and disease. Front. Cell. Neurosci. 15, 245 (2021).
Roth, T. L. et al. Transcranial amelioration of inflammation and cell death after brain injury. Nature 505, 223–228 (2014).
Sweeney, M. D., Sagare, A. P. & Zlokovic, B. V. Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat. Rev. Neurol. 14, 133–150 (2018).
Kolabas, Z. I. et al. Multi-omics and 3D-imaging reveal bone heterogeneity and unique calvaria cells in neuroinflammation. Preprint at bioRxiv https://doi.org/10.1101/2021.12.24.473988 (2021).
Giladi, A. et al. Cxcl10+ monocytes define a pathogenic subset in the central nervous system during autoimmune neuroinflammation. Nat. Immunol. 21, 525–534 (2020).
Baruch, K. et al. PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer’s disease. Nat. Med. 22, 135–137 (2016).
Krasemann, S. et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47, 566–581.e9 (2017).
Parhizkar, S. et al. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat. Neurosci. 22, 191–204 (2019).
Sayed, F. A. et al. AD-linked R47H-TREM2 mutation induces disease-enhancing microglial states via AKT hyperactivation. Sci. Transl. Med. 13, eabe3947 (2021).
Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer’s disease. Cell 169, 1276–1290.e17 (2017).
Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer’s disease and related dementias. Nat. Genet. 54, 412–436 (2022).
Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat. Genet. 51, 414–430 (2019).
Ulland, T. K. & Colonna, M. TREM2—a key player in microglial biology and Alzheimer disease. Nat. Rev. Neurol. 14, 667–675 (2018).
Yang, A. C. et al. A human brain vascular atlas reveals diverse mediators of Alzheimer’s risk. Nature 603, 885–892 (2022).
Dulken, B. W. et al. Single-cell analysis reveals T cell infiltration in old neurogenic niches. Nature 571, 205–210 (2019).
Kunis, G. et al. IFN-γ-dependent activation of the brain’s choroid plexus for CNS immune surveillance and repair. Brain J. Neurol. 136, 3427–3440 (2013).
Patel, T. K. et al. Dural lymphatics regulate clearance of extracellular tau from the CNS. Mol. Neurodegener. 14, 11 (2019).
Wightman, D. P. et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease. Nat. Genet. 53, 1276–1282 (2021).
Zhao, Z. et al. Central role for PICALM in amyloid-β blood–brain barrier transcytosis and clearance. Nat. Neurosci. 18, 978–987 (2015).
Wojtas, A. M. et al. Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways. Proc. Natl Acad. Sci. USA 114, E6962–E6971 (2017).
Simon, M. et al. Loss of perivascular aquaporin-4 localization impairs glymphatic exchange and promotes amyloid β plaque formation in mice. Alzheimers Res. Ther. 14, 59 (2022).
McFarland, H. F. & Martin, R. Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 8, 913–919 (2007).
Yednock, T. A. et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin. Nature 356, 63–66 (1992).
Zamvil, S. S. & Steinman, L. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8, 579–621 (1990).
Louveau, A. in Tertiary Lymphoid Structures: Methods and Protocols (ed. Dieu-Nosjean, M.-C.) 31–45 (Springer, 2018).
van Zwam, M. et al. Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis. J. Pathol. 217, 543–551 (2009).
Weller, M. et al. Glioma. Nat. Rev. Dis. Primer 1, 15017 (2015).
Pombo Antunes, A. R. et al. Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization. Nat. Neurosci. 24, 595–610 (2021).
Nassiri, F. et al. A clinically applicable integrative molecular classification of meningiomas. Nature 597, 119–125 (2021).
Wang, A. Z. et al. Single cell atlas of human dura reveals cellular meningeal landscape and insights into meningioma immune response. Preprint at biorXiv http://biorxiv.org/lookup/doi/10.1101/2021.08.03.454066 (2021).
Choudhury, A. et al. Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nat. Genet. 54, 649–659 (2022).
Faraco, G. et al. Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension. J. Clin. Invest. 126, 4674–4689 (2016).
Santisteban, M. M. et al. Endothelium–macrophage crosstalk mediates blood–brain barrier dysfunction in hypertension. Hypertension 76, 795–807 (2020).
Pedragosa, J. et al. CNS-border associated macrophages respond to acute ischemic stroke attracting granulocytes and promoting vascular leakage. Acta Neuropathol. Commun. 6, 76 (2018).
Winkler, E. A. et al. A single-cell atlas of the normal and malformed human brain vasculature. Science 375, eabi7377 (2022).
Sierra, C. Hypertension and the risk of dementia. Front. Cardiovasc. Med. 7, 5 (2020).
Nation, D. A. et al. Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat. Med. 25, 270–276 (2019).
Park, L. et al. Brain perivascular macrophages initiate the neurovascular dysfunction of Alzheimer Aβ peptides. Circ. Res. 121, 258–269 (2017).
Russo, M. V., Latour, L. L. & McGavern, D. B. Distinct myeloid cell subsets promote meningeal remodeling and vascular repair after mild traumatic brain injury. Nat. Immunol. 19, 442–452 (2018).
Shibata, M. et al. Clearance of Alzheimer’s amyloid-β1–40 peptide from brain by LDL receptor–related protein-1 at the blood–brain barrier. J. Clin. Invest. 106, 1489–1499 (2000).
Storck, S. E. et al. Endothelial LRP1 transports amyloid-β1–42 across the blood–brain barrier. J. Clin. Invest. 126, 123–136 (2016).
Sevigny, J. et al. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease. Nature 537, 50–56 (2016).
Salloway, S. et al. Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early Alzheimer disease. JAMA Neurol. 79, 13–21 (2022).
Knopman, D. S., Jones, D. T. & Greicius, M. D. Failure to demonstrate efficacy of aducanumab: an analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019. Alzheimers Dement. 17, 696–701 (2021).
Zhang, Y. & Zhang, Z. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell. Mol. Immunol. 17, 807–821 (2020).
Plüß, M. et al. Clinical efficacy of routinely administered belimumab on proteinuria and neuropsychiatric lupus. Front. Med. 7, 222 (2020).
Smets, I. & Titulaer, M. J. Antibody therapies in autoimmune encephalitis. Neurotherapeutics 19, 823–831 (2022).
Lutterotti, A. & Martin, R. Getting specific: monoclonal antibodies in multiple sclerosis. Lancet Neurol. 7, 538–547 (2008).
Acknowledgements
This work was conducted with funding from the Royal Society of New Zealand Rutherford Discovery Fellowship (J.R.) and National Institutes of Health grant AT010416 (J.K.), National Institutes of Health grant AG034113 (J.K.), and National Institutes of Health grant AG057496 (J.K.). We thank M. S. Barski and Reciprocal Space for the initial figure preparation.
Author information
Authors and Affiliations
Contributions
J.R. and J.K. discussed the content of the manuscript including the selection of key studies, wrote and edited the manuscript, and generated figure outlines.
Corresponding authors
Ethics declarations
Competing interests
J.K. is a member of a scientific advisory group for PureTech and holds patents and patent applications related to the findings discussed in this Review.
Peer review
Peer review information
Nature thanks Britta Engelhardt and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Rustenhoven, J., Kipnis, J. Brain borders at the central stage of neuroimmunology. Nature 612, 417–429 (2022). https://doi.org/10.1038/s41586-022-05474-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41586-022-05474-7
This article is cited by
-
Neuroimmunology and ageing – the state of the art
Immunity & Ageing (2024)
-
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Signal Transduction and Targeted Therapy (2024)
-
Osteocyte-derived sclerostin impairs cognitive function during ageing and Alzheimer’s disease progression
Nature Metabolism (2024)
-
Functional analysis of the human perivascular subarachnoid space
Nature Communications (2024)
-
Circulating myeloid-derived MMP8 in stress susceptibility and depression
Nature (2024)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.